Ovarian Carcinosarcoma research hub

EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma

This study is looking at new treatments for rare cancers called ovarian or uterine carcinosarcoma. It tests a drug called eribulin alone and with another drug, pembrolizumab, to see if they can help patients whose cancer has come back or grown. We also want to understand who might benefit most.